Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_21657 | 84 | 1.76 | Mlig455_048610 | Neo: - Age: - |
LMO1 | Mlig455_048610 {REF} {Length: 2071} {Pfam: LIM domain [PF00412.24, score=90.0]} {Human: ENSG00000166407, LMO1, LIM domain only 1, [RH, Score=186, Expect=1e-60]; ENSG00000048540, LMO3, LIM domain only 3, [RH, Score=183, Expect=2e-59]} {Mouse: ENSMUSG00000036111, Lmo1, LIM domain only 1, [RH, Score=183, Expect=1e-59]; ENSMUSG00000030226, Lmo3, LIM domain only 3, [RH, Score=183, Expect=1e-59]} {Dmel: FBgn0265598, Bx, Beadex, [RH, Score=198, Expect=1e-62]} {Celegans: WBGene00002987, lim-4, LIM domain family; Putative transcription factor LIM-4, [Score=79.3, Expect=7e-18]} {Smed: dd_Smed_v6_17422_0_1, dd_Smed_v6_17422_0_1, [RH, Score=140, Expect=6e-42]} {RNA1310_56294} {RNA815_40845} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.302 | 1.296 | 0.67929 | 1.00000 | |
RegionR2 | 0.923 | 1.296 | 0.43324 | 0.82325 | |
RegionR3 | -1.42 | 1.296 | 0.99553 | 1.00000 | |
RegionR4 | -2.323 | 1.296 | 0.99968 | 1.00000 | |
RegionR5 | -2.363 | 1.296 | 1.00000 | 1.00000 | |
RegionR6 | 0.519 | 1.296 | 0.58124 | 1.00000 | |
RegionR7 | 3.225 | 1.296 | 0.00590 | 0.12293 | |
RegionR8 | 3.742 | 1.296 | 0.00288 | 0.09262 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 1.613 | 1.296 | 0.99975 | 1.00000 | |
RegenerationR2 | -0.089 | 1.296 | 0.98218 | 1.00000 | |
RegenerationR3 | 3.202 | 1.296 | 0.03089 | 0.31432 | |
RegenerationR4 | 0.04 | 1.296 | 0.50257 | 0.87062 | |
RegenerationR5 | 4.102 | 1.296 | 0.00283 | 0.09340 | |
RegenerationR6 | 2.088 | 1.296 | 0.10524 | 0.40197 | |
RegenerationBL | 0.794 | 1.296 | 0.46239 | 0.82912 | |
RegenerationTP | 0.276 | 1.296 | 0.68890 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_21657 | 84 | 1.76 | Mlig455_048610 | Neo: - Age: - |
LMO1 | 3 | 1.000 | - | - | - | 1.000 | 1.000 | Mlig455_048610 {REF} {Length: 2071} {Pfam: LIM domain [PF00412.24, score=90.0]} {Human: ENSG00000166407, LMO1, LIM domain only 1, [RH, Score=186, Expect=1e-60]; ENSG00000048540, LMO3, LIM domain only 3, [RH, Score=183, Expect=2e-59]} {Mouse: ENSMUSG00000036111, Lmo1, LIM domain only 1, [RH, Score=183, Expect=1e-59]; ENSMUSG00000030226, Lmo3, LIM domain only 3, [RH, Score=183, Expect=1e-59]} {Dmel: FBgn0265598, Bx, Beadex, [RH, Score=198, Expect=1e-62]} {Celegans: WBGene00002987, lim-4, LIM domain family; Putative transcription factor LIM-4, [Score=79.3, Expect=7e-18]} {Smed: dd_Smed_v6_17422_0_1, dd_Smed_v6_17422_0_1, [RH, Score=140, Expect=6e-42]} {RNA1310_56294} {RNA815_40845} |
2. | MligTC455_44194 | 195 | 4.07 | Mlig455_049839, Mlig455_049886 | Neo: - Age: - |
1.786 | 0.951 | - | - | - | - | 0.835 | Mlig455_049839 {REF} {Length: 415} {RNA1509_2806, RNA1509_699} Mlig455_049886 {REF} {Length: 378} {NoTransDecoderORF} {RNA1509_2806, RNA1509_798} |
|
3. | MligTC455_33475 | 168 | 3.5 | Mlig455_036879 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.551 Region-enriched R8: 7.210/0.00005 |
1.78 | 0.980 | - | - | - | - | 0.800 | Mlig455_036879 {REF} {Length: 2954} {RNA1509_20567} {RNA1310_1034.1} {RNA815_502.1} | |
4. | MligTC455_05851 | 28 | 0.59 | Mlig455_001459 | Neo: - Age: - |
1.739 | - | - | - | - | 0.784 | 0.955 | Mlig455_001459 {REF} {Length: 1971} {Pfam: Protein of unknown function (DUF1490) [PF07371.14, score=21.7]} {RNA1310_90690} | |
5. | MligTC455_53279 | 2935 | 61.14 | Mlig455_017965 | Neo: - Age: Down-Up-Down Region-specific R8: 3.606 Region-enriched R8: 3.165/0.00000 Regeneration-downregulated BL: -2.902 Regeneration-depleted BL: -2.902 |
1.738 | 0.974 | - | - | - | - | 0.764 | Mlig455_017965 {REF} {Length: 1023} {RNA1509_20769, RNA1509_34269} {RNA1310_44808, RNA1509_20769, RNA1509_34269} {RNA1509_20769, RNA1509_34269, RNA815_8213} | |
6. | MligTC455_41805 | 2256 | 47 | Mlig455_015764, Mlig455_049489 | Neo: - Age: - Region-specific R8: 2.792 Region-enriched R8: 2.927/0.00000 |
PKD2 | 1.737 | 0.974 | - | - | - | - | 0.763 | Mlig455_015764 {REF} {Length: 3347} {Pfam: Polycystin cation channel [PF08016.14, score=395.7]; Ion transport protein [PF00520.33, score=60.8]; EF hand [PF00036.34, score=22.8]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=618, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [Score=617, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=255, Expect=3e-72]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=338, Expect=2e-104]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=660, Expect=0.0]} {RNA1509_31010} {RNA1310_4653.2} {RNA815_18688} Mlig455_049489 {REF} {Length: 3379} {Pfam: Polycystin cation channel [PF08016.14, score=493.3]; Ion transport protein [PF00520.33, score=89.5]; EF hand [PF00036.34, score=27.1]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]; EF-hand domain [PF13405.8, score=18.5]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=716, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=711, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=306, Expect=1e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=739, Expect=0.0]} {RNA1509_31010, RNA1509_51627} {RNA1310_4653.1, RNA1509_31010, RNA1509_51627} {RNA1509_31010, RNA1509_51627, RNA815_4316} |
7. | MligTC455_22776 | 28 | 0.59 | Mlig455_001677 | Neo: - Age: - |
PRKAA2 | 1.702 | - | - | - | - | 0.991 | 0.711 | Mlig455_001677 {REF} {Length: 3012} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=255.8]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=140.8]; Adenylate sensor of SNF1-like protein kinase [PF16579.7, score=35.5]; Kinase-like [PF14531.8, score=27.0]; ABC1 atypical kinase-like domain [PF03109.18, score=25.8]; RIO1 family [PF01163.24, score=21.7]} {Human: ENSG00000162409, PRKAA2, protein kinase AMP-activated catalytic subunit alpha 2, [Score=560, Expect=0.0]; ENSG00000132356, PRKAA1, protein kinase AMP-activated catalytic subunit alpha 1, [Score=542, Expect=0.0]} {Mouse: ENSMUSG00000028518, Prkaa2, protein kinase, AMP-activated, alpha 2 catalytic subunit, [Score=555, Expect=0.0]; ENSMUSG00000050697, Prkaa1, protein kinase, AMP-activated, alpha 1 catalytic subunit, [Score=535, Expect=0.0]} {Dmel: FBgn0023169, AMPKalpha, AMP-activated protein kinase alpha subunit, [Score=531, Expect=0.0]} {Celegans: WBGene00020142, aak-2, 5'-AMP-activated protein kinase catalytic subunit alpha-2, [Score=505, Expect=1e-174]} {Smed: dd_Smed_v6_2538_0_1, dd_Smed_v6_2538_0_1, [Score=551, Expect=0.0]} {RNA1509_12822, RNA1509_58504} {RNA1310_12328.1, RNA1509_12822, RNA1509_58504} {RNA1509_12822, RNA1509_58504, RNA815_3277.1} |
8. | MligTC455_38796 | 1266 | 26.37 | Mlig455_060220, Mlig455_060235 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.521/0.00003 |
BACE1 | 1.702 | 0.970 | - | - | - | - | 0.732 | Mlig455_060220 {REF} {Length: 1841} {Pfam: Eukaryotic aspartyl protease [PF00026.25, score=72.8]; Xylanase inhibitor C-terminal [PF14541.8, score=19.9]} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=215, Expect=3e-63]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=214, Expect=5e-63]} {Dmel: FBgn0032304, CG17134, [Score=56.2, Expect=3e-08]} {Celegans: WBGene00000218, asp-5, ASpartyl Protease, [Score=47.8, Expect=1e-05]} {RNA1509_48153} {RNA1310_17192, RNA1509_48153} {RNA1509_48153, RNA815_50706} Mlig455_060235 {REF} {Length: 1482} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=119, Expect=2e-29]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=118, Expect=1e-28]} {RNA1509_48153} {RNA1310_17192} {RNA815_51940} |
9. | MligTC455_46202 | 1182 | 24.63 | Mlig455_015525 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.090 Region-enriched R7: 3.843/0.00000 Regeneration-downregulated BL: -3.302 Regeneration-depleted BL: -3.302 |
1.69 | 0.954 | - | - | - | - | 0.736 | Mlig455_015525 {REF} {Length: 2230} {RNA1509_26726, RNA1509_40578, RNA1509_41769, RNA1509_55570} {RNA1310_31635.1, RNA1509_26726, RNA1509_40578, RNA1509_41769, RNA1509_55570} {RNA1509_26726, RNA1509_40578, RNA1509_41769, RNA1509_55570, RNA815_27083.1} | |
10. | MligTC455_14375 | 163 | 3.4 | Mlig455_056945 | Neo: - Age: - |
1.678 | 0.971 | - | - | - | - | 0.707 | Mlig455_056945 {REF} {Length: 1764} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=49.6]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=94.4, Expect=4e-22]} {RNA1509_48719} {RNA1310_16266.1} {RNA815_10544.2} | |
11. | MligTC455_13018 | 1993 | 41.51 | Mlig455_033923 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.482 Region-enriched R8: 5.842/0.00000 |
1.674 | 0.967 | - | - | - | - | 0.707 | Mlig455_033923 {REF} {Length: 1258} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1310_45334, RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130, RNA815_5573.2} | |
12. | MligTC455_25854 | 1015 | 21.15 | Mlig455_052672 | Neo: - Age: logFC(26M/2M)=-0.640 Region-specific R8: 3.800 Region-enriched R8: 3.703/0.00000 Regeneration-downregulated BL: -2.563 Regeneration-depleted BL: -2.563 |
1.665 | 0.950 | - | - | - | - | 0.715 | Mlig455_052672 {REF} {Length: 1364} {Pfam: PLAC8 family [PF04749.19, score=60.9]} {Smed: dd_Smed_v6_865_0_1, dd_Smed_v6_865_0_1, [Score=98.2, Expect=1e-26]} {RNA1509_58157} {RNA1310_24348, RNA1509_58157} {RNA1509_58157, RNA815_10637.1} | |
13. | MligTC455_21451 | 352 | 7.34 | Mlig455_040118, Mlig455_067333 | Neo: - Age: - Region-enriched R8: 6.038/0.00000 |
ANGPTL7 | 1.664 | 0.955 | - | - | - | - | 0.709 | Mlig455_040118 {REF} {Length: 1728} {tRNA: Val(CAC),pseudo, score=20.9} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.6]; PAN domain [PF00024.28, score=20.2]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=98.6, Expect=3e-23]; ENSG00000120332, TNN, tenascin N, [Score=98.2, Expect=2e-22]; ENSG00000171564, FGB, fibrinogen beta chain, [Score=96.7, Expect=5e-22]; ENSG00000116147, TNR, tenascin R, [Score=96.7, Expect=8e-22]; ENSG00000160339, FCN2, ficolin 2, [Score=94.0, Expect=5e-22]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=97.8, Expect=2e-22]; ENSMUSG00000015829, Tnr, tenascin R, [Score=97.8, Expect=2e-22]; ENSMUSG00000033831, Fgb, fibrinogen beta chain, [Score=95.9, Expect=5e-22]; ENSMUSG00000026938, Fcna, ficolin A, [Score=95.5, Expect=2e-22]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=94.0, Expect=8e-22]} {Dmel: FBgn0050280, CG30280, [Score=111, Expect=9e-29]} {Celegans: WBGene00020516, T15B7.1, [Score=68.2, Expect=6e-13]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=100, Expect=8e-24]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} Mlig455_067333 {REF} {Length: 1595} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=128.2]; PAN domain [PF00024.28, score=20.3]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=99.8, Expect=1e-23]; ENSG00000120332, TNN, tenascin N, [Score=99.0, Expect=2e-22]; ENSG00000171564, FGB, fibrinogen beta chain, [Score=98.2, Expect=2e-22]; ENSG00000116147, TNR, tenascin R, [Score=97.1, Expect=7e-22]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=98.2, Expect=2e-22]; ENSMUSG00000026725, Tnn, tenascin N, [Score=97.8, Expect=3e-22]; ENSMUSG00000033831, Fgb, fibrinogen beta chain, [Score=97.4, Expect=2e-22]; ENSMUSG00000026938, Fcna, ficolin A, [Score=95.5, Expect=3e-22]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=94.4, Expect=6e-22]} {Dmel: FBgn0050280, CG30280, [Score=111, Expect=8e-29]} {Celegans: WBGene00020516, T15B7.1, [Score=68.6, Expect=6e-13]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=101, Expect=4e-24]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} |
14. | MligTC455_13751 | 141 | 2.93 | Mlig455_066278 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.685 Region-enriched R7: 3.016/0.04041 |
0.983 | 0.983 | - | - | - | - | - | Mlig455_066278 {REF} {Length: 3312} {Pfam: Innexin [PF00876.20, score=292.3]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=75.9, Expect=1e-14]} {Celegans: WBGene00000488, che-7, Innexin, [Score=193, Expect=7e-55]} {Smed: dd_Smed_v6_15239_0_1, dd_Smed_v6_15239_0_1, [Score=273, Expect=1e-86]} {RNA1509_53271} {RNA1310_13768.1, RNA1509_53271} {RNA1509_53271, RNA815_19062} | |
15. | MligTC455_14600 | 206 | 4.29 | Mlig455_038122, Mlig455_039790 | Neo: - Age: - Region-enriched R8: 4.975/0.00049 |
IGFALS | 0.981 | 0.981 | - | - | - | - | - | Mlig455_038122 {REF} {Length: 2842} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=8e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=136, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=95.9, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} Mlig455_039790 {REF} {Length: 2820} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=7e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=135, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=96.3, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} |
16. | MligTC455_11926 | 101 | 2.11 | Mlig455_021319 | Neo: - Age: - Region-enriched R7: 4.905/0.00107 |
0.98 | 0.980 | - | - | - | - | - | Mlig455_021319 {REF} {Length: 2758} {Pfam: Mab-21 protein [PF03281.16, score=23.9]} {RNA1509_41055} {RNA1310_11481.1} {RNA815_44675} | |
17. | MligTC455_30986 | 631 | 13.14 | Mlig455_010831, Mlig455_033221 | Neo: - Age: - Region-enriched R7: 2.524/0.00004 Regeneration-downregulated BL: -6.030 Regeneration-depleted BL: -6.030 |
PITPNC1 | 0.978 | 0.978 | - | - | - | - | - | Mlig455_010831 {REF} {Length: 1024} {Pfam: Phosphatidylinositol transfer protein [PF02121.20, score=91.8]} {Human: ENSG00000154217, PITPNC1, phosphatidylinositol transfer protein cytoplasmic 1, [Score=88.6, Expect=3e-21]} {Mouse: ENSMUSG00000040430, Pitpnc1, phosphatidylinositol transfer protein, cytoplasmic 1, [Score=89.0, Expect=1e-21]} {Dmel: FBgn0027872, rdgBbeta, [Score=91.3, Expect=2e-22]} {Celegans: WBGene00010813, pitp-1, PhosphatidylInositol Transfer Protein family, [Score=71.2, Expect=8e-15]} {Smed: dd_Smed_v6_580_0_1, dd_Smed_v6_580_0_1, [Score=65.9, Expect=2e-13]} {RNA1509_38619} {RNA1310_18833} {RNA815_8161} Mlig455_033221 {REF} {Length: 1640} {Pfam: Phosphatidylinositol transfer protein [PF02121.20, score=237.1]} {Human: ENSG00000154217, PITPNC1, phosphatidylinositol transfer protein cytoplasmic 1, [Score=144, Expect=4e-39]} {Mouse: ENSMUSG00000040430, Pitpnc1, phosphatidylinositol transfer protein, cytoplasmic 1, [Score=145, Expect=6e-40]} {Dmel: FBgn0027872, rdgBbeta, [Score=134, Expect=1e-35]} {Celegans: WBGene00010813, pitp-1, PhosphatidylInositol Transfer Protein family, [Score=111, Expect=1e-25]} {Smed: dd_Smed_v6_7211_0_2, dd_Smed_v6_7211_0_2, [Score=114, Expect=6e-27]} {RNA1509_38619} {RNA1310_18833} {RNA815_8161} |
18. | MligTC455_33245 | 63 | 1.31 | Mlig455_070611 | Neo: - Age: Down-Up-Down |
ATMIN | 0.976 | - | - | - | - | 0.976 | - | Mlig455_070611 {REF} {Length: 4464} {TRANSSPLICED} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=27.0]; C2H2-type zinc finger [PF13894.8, score=21.1]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=20.9]} {Human: ENSG00000166454, ATMIN, ATM interactor, [RH, Score=75.5, Expect=8e-14]} {Mouse: ENSMUSG00000047388, Atmin, ATM interactor, [RH, Score=77.4, Expect=2e-14]} {Celegans: WBGene00016427, C34H4.5, [Score=48.1, Expect=9e-06]} {Smed: dd_Smed_v6_7949_0_1, dd_Smed_v6_7949_0_1, [RH, Score=77.8, Expect=2e-15]} {RNA1509_15608, RNA1509_34807} {RNA1310_15728.1, RNA1509_34807} {RNA1509_34807, RNA815_11525.1} |
19. | MligTC455_35051 | 220 | 4.58 | Mlig455_020175 | Neo: - Age: Down-Up-Down Region-enriched R8: 5.304/0.00000 |
CALM3 | 0.975 | 0.975 | - | - | - | - | - | Mlig455_020175 {REF} {Length: 927} {Pfam: EF hand [PF00036.34, score=111.3]; EF-hand domain pair [PF13499.8, score=98.6]; EF-hand domain [PF13405.8, score=91.1]; EF-hand domain pair [PF13833.8, score=78.1]; EF hand [PF13202.8, score=76.7]; EF-hand domain [PF14658.8, score=56.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=26.7]; Dockerin type I domain [PF00404.20, score=22.0]; EF-hand domain [PF17959.3, score=21.1]} {Human: ENSG00000160014, CALM3, calmodulin 3, [Score=146, Expect=5e-45]; ENSG00000198668, CALM1, calmodulin 1, [Score=146, Expect=5e-45]; ENSG00000143933, CALM2, calmodulin 2, [Score=146, Expect=5e-45]; ENSG00000178363, CALML3, calmodulin like 3, [Score=143, Expect=8e-44]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=146, Expect=3e-45]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=146, Expect=3e-45]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=146, Expect=3e-45]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=144, Expect=4e-44]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=148, Expect=8e-46]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=147, Expect=7e-46]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=147, Expect=5e-46]} {RNA1310_46966} {RNA815_26674} |
20. | MligTC455_16918 | 1218 | 25.38 | Mlig455_039085, Mlig455_042780 | Neo: - Age: Up-Down-Down Region-enriched R8: 5.308/0.00000 |
MECOM | 0.974 | 0.974 | - | - | - | - | - | Mlig455_039085 {REF} {Length: 4916} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=99.3]; C2H2-type zinc finger [PF13894.8, score=76.6]; Zinc-finger double domain [PF13465.8, score=72.4]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=41.2]; C2H2-type zinc finger [PF13912.8, score=35.0]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=25.5]; Zinc-finger of C2H2 type [PF12874.9, score=20.9]; C2H2-type zinc-finger domain [PF13909.8, score=18.4]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [RH, Score=147, Expect=6e-35]; ENSG00000142611, PRDM16, PR/SET domain 16, [RH, Score=145, Expect=3e-34]} {Mouse: ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [RH, Score=146, Expect=2e-35]; ENSMUSG00000039410, Prdm16, PR domain containing 16, [RH, Score=146, Expect=9e-35]} {Dmel: FBgn0045852, ham, hamlet, [RH, Score=149, Expect=1e-36]} {Celegans: WBGene00015646, mlt-10, [Score=172, Expect=3e-44]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [RH, Score=145, Expect=5e-38]} {RNA1509_21422} {RNA1310_3577} {RNA815_16096} Mlig455_042780 {REF} {Length: 3778} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=70.4]; Zinc-finger double domain [PF13465.8, score=59.4]; C2H2-type zinc finger [PF13894.8, score=36.4]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=29.7]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=29.0]; C2H2-type zinc finger [PF13912.8, score=28.6]; Zinc-finger of C2H2 type [PF12874.9, score=24.8]; C2H2-type zinc-finger domain [PF13909.8, score=21.2]; GAGA factor [PF09237.13, score=19.5]; C2H2 type zinc-finger (2 copies) [PF12756.9, score=18.9]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [RH, Score=141, Expect=6e-35]; ENSG00000142611, PRDM16, PR/SET domain 16, [RH, Score=139, Expect=3e-34]} {Mouse: ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [RH, Score=141, Expect=3e-35]; ENSMUSG00000039410, Prdm16, PR domain containing 16, [RH, Score=140, Expect=1e-34]} {Dmel: FBgn0032707, CG10348, [RH, Score=144, Expect=8e-37]} {Celegans: WBGene00001207, egl-43, Egl-43, [RH, Score=98.2, Expect=2e-22]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [RH, Score=144, Expect=9e-39]} {RNA1509_21422} {RNA1310_3577} {RNA815_16096} |
21. | MligTC455_20782 | 91 | 1.9 | Mlig455_066519 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.321 Region-enriched R8: 5.950/0.00576 |
0.972 | 0.972 | - | - | - | - | - | Mlig455_066519 {REF} {Length: 3710} {RNA1509_53671} {RNA1310_35957.1} {RNA815_13121.1} | |
22. | MligTC455_39971 | 147 | 3.07 | Mlig455_034549 | Neo: - Age: - Region-enriched R8: 4.475/0.00030 |
0.972 | 0.972 | - | - | - | - | - | Mlig455_034549 {REF} {Length: 2181} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.7]} {RNA1310_27858} {RNA815_17949} | |
23. | MligTC455_39972 | 142 | 2.96 | Mlig455_064814 | Neo: - Age: - Region-enriched R8: 4.539/0.00054 |
0.972 | 0.972 | - | - | - | - | - | Mlig455_064814 {REF} {Length: 2232} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=34.6]} {RNA1310_27858} {RNA815_17949} | |
24. | MligTC455_33925 | 519 | 10.82 | Mlig455_020716, Mlig455_020784 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.564/0.00000 |
0.971 | 0.971 | - | - | - | - | - | Mlig455_020716 {REF} {Length: 1635} {Pfam: Amastin surface glycoprotein [PF07344.13, score=21.1]} {RNA1310_25321} {RNA815_36976} Mlig455_020784 {REF} {Length: 2274} {Pfam: Amastin surface glycoprotein [PF07344.13, score=22.1]} {RNA1310_25321} {RNA815_36976} |
|
25. | MligTC455_37269 | 173 | 3.61 | Mlig455_020047 | Neo: - Age: - |
CASP3 | 0.971 | 0.971 | - | - | - | - | - | Mlig455_020047 {REF} {Length: 2828} {Pfam: Caspase domain [PF00656.24, score=94.7]; Ankyrin repeats (3 copies) [PF12796.9, score=79.1]; Ankyrin repeats (many copies) [PF13857.8, score=62.0]; Ankyrin repeats (many copies) [PF13637.8, score=58.0]; Ankyrin repeat [PF13606.8, score=40.7]; Ankyrin repeat [PF00023.32, score=31.7]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=111, Expect=1e-26]; ENSG00000003400, CASP10, caspase 10, [Score=107, Expect=9e-24]} {Mouse: ENSMUSG00000031628, Casp3, caspase 3, [Score=106, Expect=5e-25]; ENSMUSG00000025076, Casp7, caspase 7, [Score=106, Expect=7e-25]} {Dmel: FBgn0010501, Dcp-1, Death caspase-1, [Score=96.3, Expect=2e-21]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=81.6, Expect=9e-17]} {Smed: dd_Smed_v6_10883_0_1, dd_Smed_v6_10883_0_1, [Score=107, Expect=1e-24]} {RNA1509_54818} {RNA1310_7187} {RNA815_8712} |
26. | MligTC455_44435 | 628 | 13.08 | Mlig455_062382, Mlig455_062409 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=-0.421 Region-enriched R8: 5.635/0.00000 |
DDI2, HMCN1 | 0.97 | 0.970 | - | - | - | - | - | Mlig455_062382 {REF} {Length: 12544} {TRANSSPLICED} {Pfam: Aspartyl protease [PF09668.12, score=182.5]; gag-polyprotein putative aspartyl protease [PF13975.8, score=76.1]; Thrombospondin type 1 domain [PF00090.21, score=72.3]; Spondin-like TSP1 domain [PF19028.2, score=68.4]; Arginine repressor, C-terminal domain [PF02863.20, score=43.6]; Aspartyl protease [PF13650.8, score=34.4]; Putative vacuolating cytotoxin [PF03077.16, score=29.0]; Ubiquitin-2 like Rad60 SUMO-like [PF11976.10, score=26.1]; Thrombospondin type 1 domain [PF19030.2, score=23.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=22.2]; Retroviral aspartyl protease [PF00077.22, score=19.1]} {Human: ENSG00000197312, DDI2, DNA damage inducible 1 homolog 2, [Score=279, Expect=2e-82]} {Mouse: ENSMUSG00000078515, Ddi2, DNA-damage inducible protein 2, [Score=266, Expect=5e-78]; ENSMUSG00000047619, Ddi1, DNA-damage inducible 1, [Score=255, Expect=4e-74]} {Dmel: FBgn0030753, rngo, rings lost, [Score=275, Expect=1e-80]} {Celegans: WBGene00015308, ddi-1, Dna (DNA) Damage Inducible homolog, [Score=131, Expect=5e-32]} {Smed: dd_Smed_v6_2764_0_1, dd_Smed_v6_2764_0_1, [Score=213, Expect=1e-60]} {RNA1509_6950} {RNA1310_548} {RNA815_300} Mlig455_062409 {REF} {Length: 19342} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=78.9]; Thrombospondin type 1 domain [PF00090.21, score=74.6]; Arginine repressor, C-terminal domain [PF02863.20, score=41.0]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=32.2]; Putative vacuolating cytotoxin [PF03077.16, score=30.3]; Thrombospondin type 1 domain [PF19030.2, score=23.2]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=90.1, Expect=7e-17]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=90.5, Expect=4e-17]} {Dmel: FBgn0050046, CG30046, [Score=52.4, Expect=8e-06]} {Celegans: WBGene00000083, adt-2, ADAMTS family; ADAMTS-like protease, [Score=87.8, Expect=1e-16]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [Score=159, Expect=6e-39]} {RNA1509_21415, RNA1509_6950} {RNA1310_548, RNA1509_21415, RNA1509_6950} {RNA1509_21415, RNA1509_6950, RNA815_300} |
27. | MligTC455_07961 | 191 | 3.98 | Mlig455_051526 | Neo: - Age: - Region-enriched R8: 7.862/0.00000 Regeneration-enriched R5: 7.080 |
0.969 | 0.969 | - | - | - | - | - | Mlig455_051526 {REF} {Length: 437} {RNA815_63444} | |
28. | MligTC455_03038 | 227 | 4.72 | Mlig455_060778 | Neo: - Age: Down-Up-Down Region-enriched R8: 6.261/0.00000 |
0.968 | 0.968 | - | - | - | - | - | Mlig455_060778 {REF} {Length: 4155} {TRANSSPLICED} {tRNA: Val(CAC),pseudo, score=27.8} {Mouse: ENSMUSG00000059854, Hydin, HYDIN, axonemal central pair apparatus protein, [Score=55.1, Expect=5e-07]} {RNA1509_16236} {RNA1310_4008} {RNA815_2550} | |
29. | MligTC455_21658 | 97 | 2.02 | Mlig455_048689, Mlig455_048720 | Neo: - Age: - |
LMO1 | 0.968 | - | - | - | - | - | 0.968 | Mlig455_048689 {REF} {Length: 2106} {Pfam: LIM domain [PF00412.24, score=88.3]} {Human: ENSG00000166407, LMO1, LIM domain only 1, [RH, Score=184, Expect=1e-59]; ENSG00000048540, LMO3, LIM domain only 3, [RH, Score=181, Expect=2e-58]} {Mouse: ENSMUSG00000036111, Lmo1, LIM domain only 1, [RH, Score=181, Expect=1e-58]; ENSMUSG00000030226, Lmo3, LIM domain only 3, [RH, Score=180, Expect=2e-58]} {Dmel: FBgn0265598, Bx, Beadex, [RH, Score=196, Expect=4e-62]} {Celegans: WBGene00002987, lim-4, LIM domain family; Putative transcription factor LIM-4, [Score=79.3, Expect=8e-18]} {Smed: dd_Smed_v6_6263_0_1, dd_Smed_v6_6263_0_1, [RH, Score=139, Expect=3e-42]} {RNA1509_12583} {RNA1310_56294} {RNA815_40845} Mlig455_048720 {REF} {Length: 2081} {Pfam: LIM domain [PF00412.24, score=90.0]} {Human: ENSG00000166407, LMO1, LIM domain only 1, [RH, Score=186, Expect=1e-60]; ENSG00000048540, LMO3, LIM domain only 3, [RH, Score=183, Expect=2e-59]} {Mouse: ENSMUSG00000036111, Lmo1, LIM domain only 1, [RH, Score=183, Expect=1e-59]; ENSMUSG00000030226, Lmo3, LIM domain only 3, [RH, Score=183, Expect=1e-59]} {Dmel: FBgn0265598, Bx, Beadex, [RH, Score=198, Expect=1e-62]} {Celegans: WBGene00002987, lim-4, LIM domain family; Putative transcription factor LIM-4, [Score=79.3, Expect=7e-18]} {Smed: dd_Smed_v6_17422_0_1, dd_Smed_v6_17422_0_1, [RH, Score=140, Expect=6e-42]} {RNA1310_56294} {RNA815_40845} |
30. | MligTC455_38303 | 142 | 2.96 | Mlig455_021803 | Neo: - Age: Up-Down-Down |
PCLO | 0.967 | 0.967 | - | - | - | - | - | Mlig455_021803 {REF} {Length: 6090} {Pfam: C2 domain [PF00168.32, score=66.7]; FYVE-type zinc finger [PF02318.18, score=55.2]; Piccolo Zn-finger [PF05715.15, score=27.5]} {Human: ENSG00000186472, PCLO, piccolo presynaptic cytomatrix protein, [RH, Score=122, Expect=6e-27]} {Mouse: ENSMUSG00000061601, Pclo, piccolo (presynaptic cytomatrix protein), [RH, Score=119, Expect=2e-26]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [Score=83.2, Expect=1e-15]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=79.0, Expect=1e-14]} {Smed: dd_Smed_v6_9615_0_1, dd_Smed_v6_9615_0_1, [RH, Score=185, Expect=4e-47]} {RNA1509_42665} {RNA1310_6999} {RNA815_17846} |
31. | MligTC455_38299 | 562 | 11.71 | Mlig455_057143 | Neo: - Age: Down-Up-Down Region-enriched R8: 3.394/0.00342 |
CDX2 | 0.966 | 0.966 | - | - | - | - | - | Mlig455_057143 {REF} {Length: 2892} {Pfam: Homeodomain [PF00046.31, score=62.0]} {Human: ENSG00000165556, CDX2, caudal type homeobox 2, [RH, Score=106, Expect=4e-25]; ENSG00000113722, CDX1, caudal type homeobox 1, [RH, Score=104, Expect=7e-25]} {Mouse: ENSMUSG00000024619, Cdx1, caudal type homeobox 1, [RH, Score=104, Expect=5e-25]} {Dmel: FBgn0000251, cad, caudal, [RH, Score=103, Expect=8e-24]} {Celegans: WBGene00003912, pal-1, Homeobox protein pal-1, [RH, Score=99.4, Expect=2e-23]} {Smed: dd_Smed_v6_2442_0_1, dd_Smed_v6_2442_0_1, [Score=71.6, Expect=2e-14]} {RNA1509_20207} {RNA1310_9296.1, RNA1509_20207} {RNA1509_20207, RNA815_10543} |
32. | MligTC455_05554 | 54 | 1.12 | Mlig455_062512 | Neo: - Age: - |
0.964 | 0.964 | - | - | - | - | - | Mlig455_062512 {REF} {Length: 1169} {RNA1310_55738} {RNA815_31370.1} | |
33. | MligTC455_20781 | 5503 | 114.65 | Mlig455_066518 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.978 Region-enriched R8: 6.430/0.00000 |
FBN2 | 0.963 | 0.963 | - | - | - | - | - | Mlig455_066518 {REF} {Length: 6133} {Pfam: EGF domain [PF12947.9, score=539.9]; Calcium-binding EGF domain [PF07645.17, score=534.2]; Complement Clr-like EGF-like [PF12662.9, score=301.4]; EGF-like domain [PF00008.29, score=202.5]; Human growth factor-like EGF [PF12661.9, score=158.8]; MSP1 EGF domain 1 [PF12946.9, score=133.7]; Coagulation Factor Xa inhibitory site [PF14670.8, score=101.2]; Pvs28 EGF domain [PF06247.13, score=76.5]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=27.8]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=348, Expect=8e-98]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=350, Expect=2e-98]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-96]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=268, Expect=2e-72]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=426, Expect=1e-123]} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA1509_770} {RNA1310_1209, RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA815_317.1} |
34. | MligTC455_40223 | 172 | 3.59 | Mlig455_016264 | Neo: - Age: - Region-enriched R8: 3.704/0.01076 |
CHRNA10 | 0.963 | 0.963 | - | - | - | - | - | Mlig455_016264 {REF} {Length: 4782} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=169.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=230, Expect=2e-68]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=225, Expect=1e-66]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=233, Expect=9e-70]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=236, Expect=2e-70]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=215, Expect=6e-63]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=280, Expect=9e-87]} {RNA1509_35668} {RNA1310_11720.1} {RNA815_6827} |
35. | MligTC455_23517 | 847 | 17.64 | Mlig455_027857 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.877 Region-enriched R8: 5.900/0.00000 |
TLL1 | 0.962 | 0.962 | - | - | - | - | - | Mlig455_027857 {REF} {Length: 1443} {Pfam: Astacin (Peptidase family M12A) [PF01400.26, score=138.1]} {Human: ENSG00000038295, TLL1, tolloid like 1, [Score=95.9, Expect=7e-22]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=94.7, Expect=4e-21]} {Dmel: FBgn0037395, CG10280, [Score=102, Expect=1e-24]} {Celegans: WBGene00003534, nas-15, Zinc metalloproteinase nas-15, [Score=119, Expect=6e-30]} {Smed: dd_Smed_v6_345_0_1, dd_Smed_v6_345_0_1, [RH, Score=124, Expect=7e-34]} {RNA1509_35571} {RNA1310_3360.1} {RNA815_11450} |
36. | MligTC455_10641 | 30 | 0.63 | Mlig455_062166 | Neo: - Age: - |
0.96 | - | - | - | - | - | 0.960 | Mlig455_062166 {REF} {Length: 1081} {RNA1509_26555} {RNA1310_30156} {RNA815_39836} | |
37. | MligTC455_12451 | 63 | 1.31 | Mlig455_008444 | Neo: - Age: - Region-enriched R8: 4.645/0.00722 |
0.96 | 0.960 | - | - | - | - | - | Mlig455_008444 {REF} {Length: 791} | |
38. | MligTC455_22230 | 170 | 3.54 | Mlig455_013703, Mlig455_013720 | Neo: - Age: Down-Up-Down Region-enriched R8: 5.137/0.00004 |
0.96 | 0.960 | - | - | - | - | - | Mlig455_013703 {REF} {Length: 2025} {RNA1509_49155} {RNA1310_23836, RNA1509_49155} {RNA1509_49155, RNA815_28676} Mlig455_013720 {REF} {Length: 2031} {RNA1509_49155} {RNA1310_23836} {RNA815_28676} |
|
39. | MligTC455_28753 | 64 | 1.32 | Mlig455_018409, Mlig455_067736, Mlig455_069521 | Neo: - Age: - |
0.96 | 0.960 | - | - | - | - | - | Mlig455_018409 {REF} {Length: 979} {RNA1509_27801} {RNA1310_32897} {RNA815_15953.2} Mlig455_067736 {REF} {Length: 1136} {RNA1509_13494} {RNA1310_32897} {RNA815_15953.1} Mlig455_069521 {REF} {Length: 982} {RNA1509_27801} {RNA1310_32897} {RNA815_15953.2} |
|
40. | MligTC455_30985 | 442 | 9.22 | Mlig455_010824 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.207/0.00023 Regeneration-downregulated BL: -3.092 Regeneration-depleted BL: -3.092 |
0.958 | 0.958 | - | - | - | - | - | Mlig455_010824 {REF} {Length: 2717} {Pfam: Pao retrotransposon peptidase [PF05380.15, score=178.4]; Family of unknown function (DUF5641) [PF18701.3, score=106.4]; Integrase zinc binding domain [PF17921.3, score=34.3]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=32.6]} {Celegans: WBGene00044435, Y20F4.8, [Score=64.7, Expect=9e-11]} {Smed: dd_Smed_v6_22202_0_1, dd_Smed_v6_22202_0_1, [RH, Score=119, Expect=5e-31]} {RNA1509_9219} {RNA1310_468} {RNA815_355.1} | |
41. | MligTC455_20780 | 8892 | 185.26 | Mlig455_040314 | Neo: - Age: logFC(26M/2M)=-1.054 Region-enriched R8: 6.072/0.00000 |
NOTCH2 | 0.957 | 0.957 | - | - | - | - | - | Mlig455_040314 {REF} {Length: 15786} {Pfam: EGF domain [PF12947.9, score=500.6]; Calcium-binding EGF domain [PF07645.17, score=489.8]; Complement Clr-like EGF-like [PF12662.9, score=268.7]; EGF-like domain [PF00008.29, score=175.9]; Human growth factor-like EGF [PF12661.9, score=135.4]; MSP1 EGF domain 1 [PF12946.9, score=91.5]; von Willebrand factor type D domain [PF00094.27, score=75.8]; Coagulation Factor Xa inhibitory site [PF14670.8, score=51.8]; Pvs28 EGF domain [PF06247.13, score=34.2]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=25.7]} {Human: ENSG00000134250, NOTCH2, notch 2, [Score=246, Expect=4e-64]; ENSG00000138829, FBN2, fibrillin 2, [Score=237, Expect=3e-61]} {Mouse: ENSMUSG00000027878, Notch2, notch 2, [Score=249, Expect=6e-65]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-93]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=254, Expect=5e-67]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=415, Expect=3e-115]} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_770, RNA1509_9237} {RNA1310_1209, RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237, RNA815_317.1} |
42. | MligTC455_45987 | 1592 | 33.17 | Mlig455_024379, Mlig455_024495 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.664 Region-specific R8: 3.405 Region-enriched R8: 3.716/0.00000 Regeneration-depleted BL: -2.612 |
PKDREJ | 0.956 | 0.956 | - | - | - | - | - | Mlig455_024379 {REF} {Length: 9101} {Pfam: PKD domain [PF18911.2, score=34.9]; PKD domain [PF00801.22, score=21.5]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} Mlig455_024495 {REF} {Length: 8484} {Pfam: Polycystin cation channel [PF08016.14, score=333.9]; PLAT/LH2 domain [PF01477.25, score=69.5]; PKD domain [PF18911.2, score=32.8]; Ion transport protein [PF00520.33, score=31.6]; PKD domain [PF00801.22, score=19.8]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [RH, Score=346, Expect=8e-95]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [RH, Score=327, Expect=4e-89]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [RH, Score=319, Expect=7e-87]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=167, Expect=3e-41]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=198, Expect=3e-52]} {Smed: dd_Smed_v6_10962_0_1, dd_Smed_v6_10962_0_1, [Score=592, Expect=9e-172]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} |
43. | MligTC455_46217 | 213 | 4.43 | Mlig455_057532 | Neo: - Age: Down-Up-Down |
RBPMS2 | 0.956 | 0.956 | - | - | - | - | - | Mlig455_057532 {REF} {Length: 5470} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=53.4]} {Human: ENSG00000166831, RBPMS2, RNA binding protein, mRNA processing factor 2, [RH, Score=128, Expect=2e-35]} {Mouse: ENSMUSG00000031586, Rbpms, RNA binding protein gene with multiple splicing, [RH, Score=125, Expect=3e-35]} {Dmel: FBgn0263995, cpo, couch potato, [Score=164, Expect=7e-46]} {Celegans: WBGene00003172, mec-8, Mec-8 protein, [Score=124, Expect=4e-33]} {Smed: dd_Smed_v6_4296_0_4, dd_Smed_v6_4296_0_4, [Score=150, Expect=3e-43]} {RNA1509_30119} {RNA1310_16586.1} {RNA815_23894} |
44. | MligTC455_46216 | 1117 | 23.28 | Mlig455_057440 | Neo: - Age: - Region-enriched R7: 2.350/0.00017 |
RBPMS2 | 0.954 | 0.954 | - | - | - | - | - | Mlig455_057440 {REF} {Length: 4543} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=53.4]} {Human: ENSG00000166831, RBPMS2, RNA binding protein, mRNA processing factor 2, [RH, Score=128, Expect=2e-35]} {Mouse: ENSMUSG00000031586, Rbpms, RNA binding protein gene with multiple splicing, [RH, Score=125, Expect=3e-35]} {Dmel: FBgn0263995, cpo, couch potato, [Score=164, Expect=7e-46]} {Celegans: WBGene00003172, mec-8, Mec-8 protein, [Score=124, Expect=4e-33]} {Smed: dd_Smed_v6_4296_0_4, dd_Smed_v6_4296_0_4, [Score=150, Expect=3e-43]} {RNA1509_30119} {RNA1310_16586.1} {RNA815_23894} |
45. | MligTC455_19934 | 704 | 14.66 | Mlig455_001454 | Neo: - Age: - Region-enriched R8: 4.340/0.00000 |
HOXA10 | 0.951 | 0.951 | - | - | - | - | - | Mlig455_001454 {REF} {Length: 2331} {Pfam: Homeodomain [PF00046.31, score=71.5]; Protein of unknown function (DUF2722) [PF10846.10, score=21.4]; Anti-sigma-K factor rskA [PF10099.11, score=20.2]} {Human: ENSG00000253293, HOXA10, homeobox A10, [RH, Score=97.4, Expect=1e-21]; ENSG00000128713, HOXD11, homeobox D11, [RH, Score=95.5, Expect=2e-21]; ENSG00000170178, HOXD12, homeobox D12, [RH, Score=95.1, Expect=9e-22]; ENSG00000123407, HOXC12, homeobox C12, [RH, Score=94.7, Expect=2e-21]; ENSG00000180818, HOXC10, homeobox C10, [RH, Score=94.4, Expect=6e-21]; ENSG00000005073, HOXA11, homeobox A11, [RH, Score=92.8, Expect=2e-20]; ENSG00000128710, HOXD10, homeobox D10, [RH, Score=92.8, Expect=2e-20]} {Mouse: ENSMUSG00000000938, Hoxa10, homeobox A10, [RH, Score=97.8, Expect=5e-22]; ENSMUSG00000042499, Hoxd11, homeobox D11, [RH, Score=95.9, Expect=1e-21]; ENSMUSG00000050328, Hoxc12, homeobox C12, [RH, Score=94.7, Expect=1e-21]; ENSMUSG00000022484, Hoxc10, homeobox C10, [RH, Score=94.4, Expect=5e-21]; ENSMUSG00000001823, Hoxd12, homeobox D12, [RH, Score=94.4, Expect=1e-21]; ENSMUSG00000050368, Hoxd10, homeobox D10, [RH, Score=93.2, Expect=1e-20]} {Dmel: FBgn0000015, Abd-B, Abdominal B, [RH, Score=106, Expect=7e-25]} {Celegans: WBGene00004024, php-3, Posterior Hox gene Paralog, [RH, Score=104, Expect=2e-25]} {Smed: dd_Smed_v6_9061_0_1, dd_Smed_v6_9061_0_1, [RH, Score=132, Expect=2e-34]} {RNA1509_50329} {RNA1310_36793} {RNA815_27715} |
46. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 0.951 | 0.951 | - | - | - | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |